Galera adopts limited duration stockholder rights agreement

Malvern, pa., may 03, 2024 (globe newswire) -- galera therapeutics, inc. (nasdaq: grtx), a biopharmaceutical company focused on developing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer, today announced that its board of directors (the “board”) has unanimously resolved to adopt a limited duration stockholder rights agreement (the “rights agreement”) to protect stockholder interests.
GRTX Ratings Summary
GRTX Quant Ranking